{
    "medicine_id": "e65ec276b8509c6df79863d784a2d7f454d32f94",
    "platform_id": "DB00061",
    "metadata": {
        "name": "Adagen 250 iU 1mL Injection solution",
        "composition": "250 iU 1mL Pegademase",
        "clinical_particulars": {
            "therapeutic_indications": "For treatment of adenosine deaminase deficiency",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Used to replace deficient or inactive adenosine deaminase which leads to severe combined immunodeficiency disease SCID The enzyme is responsible for converting adenosine to inosine In the absence of adenosine deaminase the purine substrates adenosine 2 deoxyadenosine and their metabolites are actually toxic to lymphocytes thereby leading to diminished immune function",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00552",
                        "description": "The therapeutic efficacy of Pentostatin can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The therapeutic efficacy of Pegademase can be decreased when used in combination with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00019",
                        "description": "The therapeutic efficacy of Pegademase can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The therapeutic efficacy of Pegademase can be decreased when used in combination with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The therapeutic efficacy of Pegademase can be decreased when used in combination with Pegaspargase"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB01839",
                        "description": "The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB03394",
                        "description": "The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB05202",
                        "description": "The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB05321",
                        "description": "The therapeutic efficacy of PEG uricase can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB05860",
                        "description": "The therapeutic efficacy of Peginterferon alfacon 1 can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB06022",
                        "description": "The therapeutic efficacy of GlycoPEG GCSF can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB06293",
                        "description": "The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB06325",
                        "description": "The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB06611",
                        "description": "The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB06811",
                        "description": "The therapeutic efficacy of Polidocanol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The therapeutic efficacy of Peginesatide can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The therapeutic efficacy of Certolizumab pegol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The therapeutic efficacy of Peginterferon beta 1a can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB09208",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "The therapeutic efficacy of Antihemophilic Factor Recombinant PEGylated can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB11661",
                        "description": "The therapeutic efficacy of Eptacog alfa pegol activated can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB11707",
                        "description": "The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB12258",
                        "description": "The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB12578",
                        "description": "The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The therapeutic efficacy of Cepeginterferon alfa 2B can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB12839",
                        "description": "The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB12842",
                        "description": "The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB13200",
                        "description": "The therapeutic efficacy of Lipegfilgrastim can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB13933",
                        "description": "The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB14700",
                        "description": "The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB14712",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegademase"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}